Our results show that in addition to the attenuation of the IGF-IR, fenofibrate action involves accumulation of ROS, loss of mitochondrial membrane potential, and a deficit in ATP production, which taken together may explain the severe impairment of Glioma cell motility. This evidence concerns the gene IGF1R and central nervous system cancer.